Form 8.3 - Wood Group (John) Plc FORM 8.3

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
55
Form 8.3 - Wood Group (John) Plc

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code")

1.         KEY INFORMATION

(a) Full name of discloser: Kames Capital Plc
(b) Owner or controller of interests and short positions disclosed, if different from 1(a):      The naming of nominee or vehicle companies is insufficient.  For a trust, the trustee(s), settlor and beneficiaries must be named.  
(c) Name of offeror/offeree in relation to whose relevant securities this form relates:      Use a separate form for each offeror/offeree John Wood Group Plc
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:  
(e) Date position held/dealing undertaken:      For an opening position disclosure, state the latest practicable date prior to the disclosure 01/06/2017
(f)  In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?      If it is a cash offer or possible cash offer, state "N/A" NO If YES, specify which:

2.         POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a)        Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:   Ordinary Share
    Interests Short positions
Number % Number %
(1) Relevant securities owned and/or controlled: 6,523,158 1.712 0 0.00
(2) Cash-settled derivatives:   1,466,495 0.3849 0 0.00
(3) Stock-settled derivatives (including options) and agreements to purchase/sell: 0 0.00 0 0.00
       TOTAL: 7,989,653 2.0969 0 0.00

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b)        Rights to subscribe for new securities (including directors' and other employee options)

Class of relevant security in relation to which subscription right exists:  
Details, including nature of the rights concerned and relevant percentages:  

3.         DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a)        Purchases and sales

Class of relevant security Purchase/sale   Number of securities Price per unit
       

(b)        Cash-settled derivative transactions

Class of relevant security Product description e.g. CFD Nature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short position Number of reference securities Price per unit
Ordinary Share CFD Reducing a long position 31,015 7.1625 GBP

(c)        Stock-settled derivative transactions (including options)

(i)         Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type e.g. American, European etc. Expiry date Option money paid/ received per unit
               

(ii)        Exercise

Class of relevant security Product description e.g. call option Exercising/ exercised against Number of securities Exercise price per unit
         

(d)        Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing e.g. subscription, conversion Details Price per unit (if applicable)
       

4.         OTHER INFORMATION

(a)        Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included.  If there are no such agreements, arrangements or understandings, state "none"
  None  

(b)        Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i)  the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state "none"
     

(c)        Attachments

Is a Supplemental Form 8 (Open Positions) attached?  
Date of disclosure: 02/06/2017
Contact name: Stephen Adams
Telephone number: 0131 549 6714 For any issues relating to this disclosure please contact 0141 549 3288  or kamestradeoperationsmb@kamescapital.com

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk .  The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk .

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lilly's $3.5B Bet: Next-Gen Obesity Drug Site

Updated Category News Views 82

Pennsylvania Becoming a Pharma Hub There's a big pharma shuffle happening in the heart of Pennsylvania, folks. Eli Lilly's throwing a whopping $3.5 billion into a new facility in Lehigh Valley, marking it the latest pawn in their larger $50 billion strategy to bolster medicine production right here in the U.S. You talk about commitment, and this investment is no small...

Continue Reading
ATI's Aggressive 2029 Targets: A Bold Vision Unveiled

Updated Category News Views 23

ATI's Strategy: No Rest for the Ambitious So, ATI (NYSE:ATI) isn't just sitting on its hands, staring at numbers from the last fiscal year. They're out here, shaking up the market with some serious plans. At their Investor Day shindig, they dished out a strategy as bold as breakfast coffee—targeting double-digit growth and expanded margins by 2029. Call it audacious or...

Continue Reading
Drip Gym Brings Iron Infusions Home Nationwide

Updated Category News Views 35

Revamping Iron Deficiency Treatment Nationwide Now here's something to ponder over your morning coffee: Drip Gym, a New York-based IV therapy outfit, has made it possible for folks all across the U.S. to get hospital-grade iron infusions right from the comfort of their living rooms. Imagine dealing with your iron levels between episodes of your favorite show, instead of...

Continue Reading
Implantica's Q3 2026: A Potential Leap Forward?

Updated Category News Views 29

Implantica Prepares to Unveil Q3 Results We're heading into the home stretch for 2026, and Implantica's about to unveil its third-quarter results. With its presentation scheduled for November 19 at 15:00 CET, this medtech outfit has caught some eyes, especially with their flagship offering, RefluxStop®. Paying attention here might be worthwhile, as this plays into a...

Continue Reading
University of Phoenix Tackles Data: New Degree Insight

Updated Category News Views 33

Giving Traditional Business Schools a Run for Their Money It's about time someone ditches that outdated case study method and starts teaching folks how to really harness data. Enter the University of Phoenix's new Bachelor of Science in Business Analytics. It's designed with working adults in mind. Wherever you are, this ain't your everyday degree program. It's an online...

Continue Reading
Pentixapharm Extends Convertible Bond to 2030

Updated Category News Views 49

Pentixapharm and Eckert & Ziegler's Extended Bond Play Fresh off the Berlin newswire, Pentixapharm Holding AG made a bold move with Eckert & Ziegler SE (EZAG). This isn't your everyday handshake, folks. We're talking about extending a 4.00% convertible bond from 2027 all the way out to 2030. There's a twist: the interest rate's ticking up to 6.00% starting in 2027. So,...

Continue Reading
Eligible Inc Earns X12 Certification, Boosting Efficiency

Updated Category News Views 34

Highlighting a Key Milestone for Eligible Inc Eligible Inc, that name might not mean much to your average Jane or Joe, but in the inner circles of healthcare administration, it's making serious waves. On November 12, 2026, they proudly announced bagging the X12 Certification Seals for pivotal operations. This ain't just the company handing out participation...

Continue Reading
HSG Laser Boosts EU Presence with Düsseldorf Showroom

Updated Category News Views 97

HSG Laser Makes a Bold Move in Europe When you're ripping off the band-aid and just diving into the hard truth, it's no small potatoes that HSG Laser has kicked open the doors to a shiny new showroom in Düsseldorf, Germany. This ain't just another brick in the wall—it's a sprawling 2,000 m² facility that marks a 20-year track record of tackling the European sector...

Continue Reading
Xinjiang Farmer Cultivates Community Success and Skills

Updated Category News Views 134

Growing Opportunities Beyond Tradition Zhang Xiying in Urumqi county, Xinjiang Uygur Autonomous Region, is rewriting the farming script with unflagging effort. She's not just tending to her own crops; she's nurturing a whole ecosystem of farmers who're hungry to branch out beyond traditional harvests. Picture this—a farmer turned agricultural technician, helping 19...

Continue Reading
Global Challenge: A New Era for AI Web Agents

Updated Category News Views 118

The Dawn of the Agent Web Well, here we are, standing at the cusp of a new digital frontier, folks. This ain't just another buzzword parade; this is the Open Agentic Web Challenge, courting developers with a $13K carrot to craft an interoperable playground for AI agents. Big names like Cognizant AI Lab, MIT Media Lab, and others are leading the charge. No small-time...

Continue Reading

Top 5 Most Recently Viewed Articles

Nipocalimab's Unique Design for IgG-Driven Diseases Explored

Updated Category News Views 254

Nipocalimab: A Breakthrough in Treating IgG-Driven Diseases Nipocalimab has emerged as a promising investigational treatment in the realm of IgG-driven alloantibody and autoantibody diseases. Recent results affirm its high-affinity binding characteristics and immunoselective properties. This groundbreaking monoclonal antibody has been shown to significantly reduce IgG...

Continue Reading
FTI Consulting Achieves Robust Earnings Despite Market Challenges

Updated Category News Views 64

FTI Consulting Reports Third Quarter Financial Results FTI Consulting, Inc. (NYSE: FCN) recently announced its financial performance for the third quarter, presenting a noteworthy achievement with earnings of $926 million, marking an increase compared to the previous year. This growth reflects the company's resilience and capacity to adapt amidst fluctuating market...

Continue Reading
FutureFuel Secures Key Approval for Clean Fuel Production

Updated Category News Views 331

FutureFuel Achieves Excise Tax Registration Approval FutureFuel Corp. (NYSE: FF), a leading player in the manufacturing of custom and performance chemicals and biofuels, has recently celebrated a significant success. The company has received its Excise Tax Registration approval from the Internal Revenue Service (IRS). This vital registration marks the first step towards...

Continue Reading
Natural Gas Services Group Increases 2024 EBITDA Guidance

Updated Category News Views 92

Natural Gas Services Group Announces Strong Q3 2024 Results Natural Gas Services Group, Inc. (NYSE: NGS), a prominent provider in the natural gas compression industry, has released its financial results for the third quarter ending September 30, 2024. The company reported significant growth in rental revenue, cash flow from operating activities, and net income, signifying...

Continue Reading
Apple's Leap Forward: C2 Modem Testing Signals 5G Advances

Updated Category News Views 331

Apple Inc. Enters a New Era with C2 Modem Testing Apple Inc. (NASDAQ: AAPL) is taking significant steps in advancing its connectivity technology by reportedly testing its second-generation C2 modem for the upcoming iPhone models. Latest Developments in Modem Technology Recently, a reliable source on X, previously known as Twitter, revealed that Apple is currently in the...

Continue Reading